Systematic integration of additional variables, such as peripheral immune-cell ratios, tumor-infiltrating lymphocyte composition, and checkpoint-molecule expression (e.g., PD-1, PD-L1, and CTLA-4), would markedly enhance dataset granularity and biological interpretability. The gene discussed is CTLA4; the disease is neoplasm.